IGM Biosciences, Inc. (IGMS)
Au 14, 2025 - IGMS was delisted (reason: acquired by Concentra Biosciences)
1.270
-0.030 (-2.31%)
Inactive · Last trade price on Aug 13, 2025

IGM Biosciences Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for IGM Biosciences stock had an average target of $6.00, with a low estimate of $1.00 and a high estimate of $22.

Price Target: $6.00 (+372.44%)
Analyst Consensus: Hold

Price Target

TargetLowAverageMedianHigh
Price$1.00$6.00n/a$22
Change-21.26%+372.44%n/a+1632.3%

Analyst Ratings

The average analyst rating for IGM Biosciences stock from 8 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
9.44M
from 2.68M
Increased by 252.44%
Revenue Next Year
13.83M
from 9.44M
Increased by 46.48%
EPS This Year
-1.30
from -3.24
EPS Next Year
-1.19
from -1.30
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
--1.07M2.13M2.68M9.44M13.83M
Revenue Growth
---99.25%25.78%252.44%46.48%
EPS
-2.65-4.93-5.32-4.71-3.24-1.30-1.19
No. Analysts
-----76

Revenue Forecast

Revenue20252026202720282029
High25.2M25.2M
Avg9.4M13.8M
Low1.7M3.0M

Revenue Growth

Revenue Growth20252026202720282029
High
841.4%
167.1%
Avg
252.4%
46.5%
Low
-36.0%
-67.8%

EPS Forecast

EPS202520262027
High-0.09-0.06
Avg-1.30-1.19
Low-2.29-2.23

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--